These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Risk factors for loco-regional recurrence after radical cystectomy of muscle-invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy. Sargos P; Baumann BC; Eapen L; Christodouleas J; Bahl A; Murthy V; Efstathiou J; Fonteyne V; Ballas L; Zaghloul M; Roubaud G; Orré M; Larré S Cancer Treat Rev; 2018 Nov; 70():88-97. PubMed ID: 30125800 [TBL] [Abstract][Full Text] [Related]
3. [Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]. Sargos P; Larré S; Chapet O; Latorzeff I; Fléchon A; Roubaud G; Orré M; Belhomme S; Richaud P Cancer Radiother; 2017 Feb; 21(1):67-72. PubMed ID: 28187997 [TBL] [Abstract][Full Text] [Related]
4. Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer: a phase II trial. Fonteyne V; Dirix P; Junius S; Rammant E; Ost P; De Meerleer G; Swimberghe M; Decaestecker K BMC Cancer; 2017 May; 17(1):308. PubMed ID: 28464906 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study. Orré M; Latorzeff I; Fléchon A; Roubaud G; Brouste V; Gaston R; Piéchaud T; Richaud P; Chapet O; Sargos P PLoS One; 2017; 12(4):e0174978. PubMed ID: 28384195 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant Radiotherapy Use by US Radiation Oncologists After Radical Cystectomy for Muscle-invasive Bladder Cancer. Solanki AA; Martin B; Korpics M; Small C; Harkenrider MM; Mitin T Clin Oncol (R Coll Radiol); 2017 Jul; 29(7):429-435. PubMed ID: 28242163 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
8. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients. Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C Breast J; 2014; 20(4):381-7. PubMed ID: 24890310 [TBL] [Abstract][Full Text] [Related]
9. Lymphadenectomy in bladder cancer: how high is "high enough"? Stein JP Urol Oncol; 2006; 24(4):349-55. PubMed ID: 16818190 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density. Stein JP; Cai J; Groshen S; Skinner DG J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639 [TBL] [Abstract][Full Text] [Related]
11. A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Baumann BC; Guzzo TJ; He J; Keefe SM; Tucker K; Bekelman JE; Hwang WT; Vaughn DJ; Malkowicz SB; Christodouleas JP Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):81-8. PubMed ID: 22543204 [TBL] [Abstract][Full Text] [Related]
12. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes. Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
14. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
15. Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy. Reddy AV; Pariser JJ; Pearce SM; Weichselbaum RR; Smith ND; Steinberg GD; Liauw SL Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1031-9. PubMed ID: 27026309 [TBL] [Abstract][Full Text] [Related]
16. A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer. El-Monim HA; El-Baradie MM; Younis A; Ragab Y; Labib A; El-Attar I Urol Oncol; 2013 Apr; 31(3):359-65. PubMed ID: 21353794 [TBL] [Abstract][Full Text] [Related]
17. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847 [TBL] [Abstract][Full Text] [Related]
18. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797 [TBL] [Abstract][Full Text] [Related]
19. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy? Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679 [TBL] [Abstract][Full Text] [Related]